Oxacillin for Injection, USP, 10 gram per pharmacy Bulk Package bottle, For Intravenous Use, Rx o...

FDA Recall #D-0937-2023 — Class II — July 11, 2023

Recall #D-0937-2023 Date: July 11, 2023 Classification: Class II Status: Ongoing

Product Description

Oxacillin for Injection, USP, 10 gram per pharmacy Bulk Package bottle, For Intravenous Use, Rx only, packaged as a) NDC 25021-163-99 and b) novaplus NDC 25021-163-68, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. Made in India.

Reason for Recall

Lack of Assurance of Sterility

Recalling Firm

Sagent Pharmaceuticals — Schaumburg, IL

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

760 bottles

Distribution

Nationwide in the USA

Code Information

Lot: a) OXT202, exp 5/31/2025; OXT203, exp 5/31/2025; OXT301, exp 12/31/2025; b) OXT205, exp 6/30/2025; OXT204, exp 5/31/2025

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated